1 | (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4’- | - | - | - | - | 1件: 79 79 |
2 | 1,2-Dihexadecanoyl-sn-Glycero-3-Phospho-(1-raac-glycerol) | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
3 | [AMG 145] | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
4 | [Lomitapide 2mg hard capsules] | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
5 | [NA] | 1件: Vedolizumab Vedolizumab | 1件: D08083
D08083
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 25件: 3 3, 6, 11, 13, 14, 28, 35, 41, 46, 49, 50, 53, 62, 63, 65, 75, 79, 96, 97, 98, 222, 229, 288, 294, 299 |
6 | [PRD7255830] | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
7 | [PRD7255977] | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
8 | [PRD7256003] | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
9 | [R727] | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
10 | [REGN1500] | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
11 | [REGN7272] | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
12 | AAV directed hLDLR gene therapy | - | - | - | - | 1件: 79 79 |
13 | AAV8.TBG.hLDLR | - | - | - | - | 1件: 79 79 |
14 | Acetate | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
15 | AEGR-733 | - | - | - | - | 1件: 79 79 |
16 | AK102 | 1件: Ezetimibe Ezetimibe | 1件: D01966
D01966
| 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
17 | AKCEA-ANGPTL3-LRX | - | - | - | - | 2件: 79 79, 265 |
18 | ALIROCUMAB | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
19 | Alirocumab SAR236553 (REGN727) | 1件: Pravastatin Pravastatin | 2件: D00893
D00893
,
D08410
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
20 | ALN-60212 | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
21 | ALN-PCSSC | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
22 | AMG 145 | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
23 | AMG145 | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
24 | ANACETRAPIB | 1件: Anacetrapib Anacetrapib | 1件: D08855
D08855
| 1件: CETP CETP 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
25 | Atorvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 18件: 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
26 | Calcium | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 30件: 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
27 | Calcium rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
28 | CER-001 | - | - | - | - | 1件: 79 79 |
29 | Cholestyramine | 1件: Cholestyramine Cholestyramine | - | - | - | 2件: 13 13, 79 |
30 | Comparator: ezetimibe | 1件: Ezetimibe Ezetimibe | 1件: D01966
D01966
| 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 2件: 79 79, 260 |
31 | Crestor | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 49 49, 79, 299 |
32 | Crestor Film-Coated Tablet | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
33 | Crestor Tablets (calcium rosuvastatin) Film-Coated tablets | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
34 | Current lipid-lowering treatment | 1件: Acetate Acetate | - | - | - | 1件: 79 79 |
35 | Dextran | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 5件: 2 2, 62, 79, 96, 97 |
36 | Dextran sulfate adsorption | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 79 79 |
37 | DPPG | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
38 | EVINACUMAB | 1件: Evinacumab Evinacumab | 1件: D11753
D11753
| 1件: ANGPTL3 ANGPTL3 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
39 | Evinacumab (REGN1500) | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
40 | EVOLOCUMAB | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 2件: 79 79, 222 |
41 | Evolocumab (AMG 145) | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
42 | Ezetimibe | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 4件: 49 49, 79, 93, 260 |
43 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 5件: 8 8, 79, 93, 94, 265 |
44 | Fluvastatin | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 79 79, 218, 222 |
45 | Gemcabene | 1件: Gemcabene Gemcabene | - | - | - | 2件: 79 79, 265 |
46 | Glycerol | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 5件: 6 6, 13, 79, 316, 317 |
47 | Heparin | 1件: Benazepril Benazepril | 2件: D00620
D00620
,
D07499
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 12件: 47 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 |
48 | Heparin-induced extracorporeal LDL precipitation | 1件: Heparin Heparin | 1件: D07510
D07510
| 1件: SERPINC1 SERPINC1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 79 79 |
49 | IBI306 | - | - | - | - | 1件: 79 79 |
50 | Implitapide | 1件: Implitapide Implitapide | - | - | - | 1件: 79 79 |
51 | Inclisiran | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
52 | Inclisiran for injection | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
53 | Inclisiran Sodium | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
54 | ISIS 301012 | - | - | - | - | 1件: 79 79 |
55 | ISIS 301012 phosphorothioate oligonucleotide | - | - | - | - | 1件: 79 79 |
56 | ISIS 703802 | - | - | - | - | 1件: 79 79 |
57 | JS002 | - | - | - | - | 1件: 79 79 |
58 | KJX839 | 1件: Inclisiran Inclisiran | 1件: D11931
D11931
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
59 | Lapaquistat | 1件: Acetate Acetate | - | - | - | 1件: 79 79 |
60 | Lapaquistat acetate and current lipid-lowering treatment | 1件: Acetate Acetate | - | - | - | 1件: 79 79 |
61 | Lerodalcibep | - | - | - | - | 1件: 79 79 |
62 | LIB003 | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
63 | Lojuxta | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
64 | Lojuxta 10 mg hard capsules | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
65 | Lojuxta 20 mg hard capsules | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
66 | Lojuxta 5 mg hard capsules | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
67 | LOMITAPIDE | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
68 | Lomitapide 2mg hard capsules | 1件: Lomitapide Lomitapide | 1件: D09637
D09637
| 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
69 | Lovastatin | 1件: Lovastatin Lovastatin | 1件: D00359
D00359
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 |
70 | MBX-8025 | 1件: Seladelpar Seladelpar | 1件: D11256
D11256
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 3件: 79 79, 93, 94 |
71 | MBX-8025 50 mg (Dose Escalation Period 1) | - | - | - | - | 1件: 79 79 |
72 | MBX-8025 50 mg or 100 mg (Dose Escalation Period 2) | - | - | - | - | 1件: 79 79 |
73 | MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3) | - | - | - | - | 1件: 79 79 |
74 | Mipomersen | 1件: Mipomersen Mipomersen | - | - | - | 1件: 79 79 |
75 | MK-0859 | - | - | - | - | 1件: 79 79 |
76 | Nicotinic acid | 1件: Pravastatin Pravastatin | 2件: D00893
D00893
,
D08410
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
77 | Omega-3 | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 7件: 13 13, 46, 49, 66, 79, 96, 299 |
78 | Omega-3 fatty acids | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 2件: 13 13, 79 |
79 | Phospholipids | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
80 | Placebo | 1件: Guselkumab Guselkumab | 1件: D10438
D10438
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 27件: 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
81 | Praluent | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
82 | Pravastatin | 1件: Pravastatin Pravastatin | 2件: D00893
D00893
,
D08410
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 9件: 13 13, 46, 49, 67, 79, 96, 164, 265, 333 |
83 | Prednisone | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
84 | R727 | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
85 | Recombinant Human Apolipoprotein | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
86 | Recombinant Human Apolipoprotein A-I | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
87 | Recombinant Human Apolipoprotein A-I/Phospholipids Complex | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
88 | Recombinant human apolipoprotein a1 | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
89 | REGN1500 | 1件: Evinacumab Evinacumab | 1件: D11753
D11753
| 1件: ANGPTL3 ANGPTL3 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
90 | REGN1500 250 mg SC/15 mg/kg IV/450 mg SC | - | - | - | - | 1件: 79 79 |
91 | Repatha | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
92 | Repatha (evolocumab) | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
93 | Repatha 140 mg Solution for Injection in Pre-filled Pen | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
94 | Repatha 140 mg soluzione per iniezione in penna preriempita. | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
95 | Repatha 420 mg solution for injection in cartridge | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
96 | Repatha 420 mg soluzione per iniezione in cartuccia | 1件: Evolocumab Evolocumab | 1件: D10557
D10557
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
97 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
98 | Rosuvastatin 20mg | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |
99 | ROSUVASTATIN CALCIUM | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 4件: 49 49, 79, 97, 299 |
100 | SAR236553 | 1件: Alirocumab Alirocumab | 1件: D10335
D10335
| 1件: PCSK9 PCSK9 💬 | 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 |
101 | Sfingomielina | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
102 | SHR-1209 | - | - | - | - | 1件: 79 79 |
103 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
104 | Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy | - | - | - | - | 1件: 79 79 |
105 | Sphingomyelin | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 1件: 79 79 |
106 | Standard of Care | - | - | - | - | 10件: 6 6, 13, 46, 49, 51, 63, 64, 79, 171, 271 |
107 | Statins | 1件: Angiotensin II Angiotensin II | 2件: D00150
D00150
,
D02014
| 2件: AGTR1 AGTR1, AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 46 46, 79 |
108 | Sulfate | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
109 | TAK-475 | 1件: TAK-475 TAK-475 | - | - | - | 1件: 79 79 |
110 | ZD4522 | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 |